Alyce S. Adams

Alyce Adams, Stanford Health Policy Profile 2022

Alyce S. Adams , PhD, MPP

  • Stanford Medicine Innovation Professor
  • Professor, Epidemiology and Population Health
  • Professor, Health Policy
  • Professor, Pediatrics (by courtesy)

Biography

Alyce Adams is the inaugural Stanford Medicine Innovation Professor and Professor of Health Policy, Epidemiology and Population Health and of Pediatrics (by Courtesy). She also serves as Associate Chair for Community Outreach and Engagement for Stanford Health Policy, and as Associate Director for Partnership and Community Engagement in the Stanford Cancer Institute. Focusing on pharmaceutical treatments for cancer and diabetes, Dr. Adams' research evaluates health system and policy level interventions to improve access, balance the benefits and harms of treatment, improve patient-valued outcomes, and reduce disparities.

In The News

Illustration of healthcare costs
News

Policy Brief: The Measurable Impact of MFA Programs in Cancer Care and Beyond

In a new policy brief, SHP's Alyce Adams and her colleague, Mateen Ghassemi, address financial toxicity in cancer care through Medical Financial Assistance (MFA) Policy.
Policy Brief: The Measurable Impact of MFA Programs in Cancer Care and Beyond
Stanford Health Policy's Alyce Adams addresses AI conference
News

Legal Risks and Rewards of Artificial Intelligence in Health Care

Stanford Health Policy researchers address issues of liability risk and the ethical use of AI in health care, making the case for tools that address liability and risk—while making patient safety and concerns a priority.
Legal Risks and Rewards of Artificial Intelligence in Health Care
An artistic illustration of human kidneys
News

Balancing Efficiency and Equity in Screening for Chronic Kidney Disease

More than one in seven adults in the United States are believed to have chronic kidney disease, with the burden disproportionately impacting Black and Hispanic adults. A new Stanford study suggests a population-wide CKD screening could reduce these disparities.
Balancing Efficiency and Equity in Screening for Chronic Kidney Disease